This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Terremoto Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Solomon H. Reisberg: Innovator in AKT1 Modulation
Introduction
Solomon H. Reisberg is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of AKT1, a crucial protein involved in various cellular processes.
Latest Patents
Reisberg holds 2 patents, with his latest inventions focusing on non-covalent modifiers of AKT1. These patents include methods and pharmaceutical compositions that utilize compounds of specific formulas to modulate wild-type AKT1. His work provides innovative approaches to potentially treat various diseases by targeting this important protein.
Career Highlights
Reisberg is currently associated with Terremoto Biosciences, Inc., where he continues to advance his research and development efforts. His expertise in the field has positioned him as a key player in the biotechnology sector.
Collaborations
One of his notable collaborators is Hang Chu, with whom he has worked closely on various projects related to AKT1 modulation.
Conclusion
Solomon H. Reisberg's contributions to the field of biotechnology and his innovative patents highlight his role as a significant inventor in the modulation of AKT1. His work continues to pave the way for advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile